A Cancer Control Report Card and Blueprint
This first chapter in the American Cancer Society Cancer Control Blueprint sets up the steps to take in the future to lower the incidence and death rate of cancer by looking at what's led to success in the past. It's delivered by staff researcher Rebecca Siegel, MPH, scientific director of surveillance information.
Cancer Patients Want More Information From Doctors About Cost
A study led by researchers from University of Michigan has found that many cancer patients would like more help from their health care providers in addressing costs of treatment.
How Safe is Your Sunscreen?
The American Cancer Society recommends sunscreen to protect your skin, but some groups have raised concerns over ingredients found in some sunscreens.
FDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
The ACS Blueprint: A Vision for Reducing Deaths from Cancer
The American Cancer Society Cancer Control Blueprint—introduced by an interview with Otis W. Brawley, MD, MACP, chief medical and scientific officer of the ACS. The blueprint, says Brawley, is both a celebration of our progress against cancer and a call to action to do even better.
What Is Cancer Control?
We talk about "cancer control" all the time, but what does it really mean? How does it relate to "cancer burden?" Find out.
FDA Approves Azedra (Iobenguane) for Rare Adrenal Tumors
The US Food and Drug Administration has approved the radiotherapy drug Azedra (iobenguane I-131) to treat some adults and adolescents ages 12 and older with rare tumors of the adrenal gland called pheochromocytomas, as well as for similar tumors outside of the adrenals, called paragangliomas.
Healthier Lunchbox Options
Get off to a delicious start this school year with our ideas for good-for-you lunchbox fillers your kids will love, and get some inspirations for your own healthy lunches, too!